These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22891125)

  • 1. Cost-effectiveness analysis of TAVR.
    Reardon MJ
    Methodist Debakey Cardiovasc J; 2012; 8(2):26-8. PubMed ID: 22891125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies assessing transcatheter aortic valve replacement.
    Raheem S; Popma JJ
    Methodist Debakey Cardiovasc J; 2012; 8(2):13-8. PubMed ID: 22891122
    [No Abstract]   [Full Text] [Related]  

  • 3. Transcatheter aortic valve replacement (TAVR): access planning and strategies.
    Ramlawi B; Anaya-Ayala JE; Reardon MJ
    Methodist Debakey Cardiovasc J; 2012; 8(2):22-5. PubMed ID: 22891124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality noninvasive imaging for transcatheter aortic valve implantation: a primer.
    Little SH; Shah DJ; Mahmarian JJ
    Methodist Debakey Cardiovasc J; 2012; 8(2):29-37. PubMed ID: 22891126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).
    Reynolds MR; Magnuson EA; Lei Y; Wang K; Vilain K; Li H; Walczak J; Pinto DS; Thourani VH; Svensson LG; Mack MJ; Miller DC; Satler LE; Bavaria J; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2012 Dec; 60(25):2683-92. PubMed ID: 23122802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B).
    Reynolds MR; Magnuson EA; Wang K; Lei Y; Vilain K; Walczak J; Kodali SK; Lasala JM; O'Neill WW; Davidson CJ; Smith CR; Leon MB; Cohen DJ;
    Circulation; 2012 Mar; 125(9):1102-9. PubMed ID: 22308299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Room considerations with TAVR.
    Kleiman N
    Methodist Debakey Cardiovasc J; 2012; 8(2):19-21. PubMed ID: 22891123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.
    Reynolds MR; Lei Y; Wang K; Chinnakondepalli K; Vilain KA; Magnuson EA; Galper BZ; Meduri CU; Arnold SV; Baron SJ; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    J Am Coll Cardiol; 2016 Jan; 67(1):29-38. PubMed ID: 26764063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.
    Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ
    Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
    Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants.
    Ribera A; Slof J; Andrea R; Falces C; Gutiérrez E; Del Valle-Fernández R; Morís-de la Tassa C; Mota P; Oteo JF; Cascant P; Altisent OA; Sureda C; Serra V; García-Del Blanco B; Tornos P; Garcia-Dorado D; Ferreira-González I
    Int J Cardiol; 2015 Mar; 182():321-8. PubMed ID: 25585368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Self-Expandable Transcatheter Aortic Valves in Intermediate-Risk Patients.
    Tam DY; Hughes A; Wijeysundera HC; Fremes SE
    Ann Thorac Surg; 2018 Sep; 106(3):676-683. PubMed ID: 29730344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic assessment of traditional surgical valve replacement versus use of transfemoral intervention in degenerative aortic stenosis.
    Edlinger C; Krizanic F; Butter C; Bannehr M; Neuss M; Fejzic D; Hoppe UC; Lichtenauer M
    Minerva Med; 2021 Jun; 112(3):372-383. PubMed ID: 32491292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.
    Arnold SV; Reynolds MR; Wang K; Magnuson EA; Baron SJ; Chinnakondepalli KM; Reardon MJ; Tadros PN; Zorn GL; Maini B; Mumtaz MA; Brown JM; Kipperman RM; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1207-1217. PubMed ID: 26292584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness considerations in transcatheter management of valvular heart disease.
    Gadey G; Reynolds MR
    Can J Cardiol; 2014 Sep; 30(9):1058-63. PubMed ID: 24999170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation transcatheter heart valves: current trials in Europe and the USA.
    Sinning JM; Werner N; Nickenig G; Grube E
    Methodist Debakey Cardiovasc J; 2012; 8(2):9-12. PubMed ID: 22891121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following transcatheter aortic valve replacement in the United States.
    Mack MJ; Brennan JM; Brindis R; Carroll J; Edwards F; Grover F; Shahian D; Tuzcu EM; Peterson ED; Rumsfeld JS; Hewitt K; Shewan C; Michaels J; Christensen B; Christian A; O'Brien S; Holmes D;
    JAMA; 2013 Nov; 310(19):2069-77. PubMed ID: 24240934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
    Doble B; Blackhouse G; Goeree R; Xie F
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic valve replacement: design, clinical application, and future challenges.
    Forrest JK
    Yale J Biol Med; 2012 Jun; 85(2):239-47. PubMed ID: 22737052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of transcatheter aortic valve implantation (TAVI) versus conventional aortic valve replacement in the treatment of aortic valve disease.
    Lawrie GM
    Methodist Debakey Cardiovasc J; 2012; 8(2):4-8. PubMed ID: 22891120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.